期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Extraction Technology of Total Flavonoids from Pueraria lobata (Willd.) Ohwi and Content Determination of Pueraria lobata (Willd.) Ohwi at Different Altitudes 被引量:2
1
作者 Chunlin liU yingchen li +1 位作者 Bochao li Yuan liU 《Medicinal Plant》 2017年第2期12-14,18,共4页
[Objectives]To optimize the extraction technology of total flavonoids from Pueraria lobata( Willd.) Ohwi. [Methods]The ultraviolet-visible spectrophotometry was used to determine the content of total flavonoids in Pue... [Objectives]To optimize the extraction technology of total flavonoids from Pueraria lobata( Willd.) Ohwi. [Methods]The ultraviolet-visible spectrophotometry was used to determine the content of total flavonoids in Pueraria lobata( Willd.) Ohwi. With the puerarin as index,the reflux extraction and single factor test were employed to investigate the effects of temperature,time,ethanol concentration and solid-liquid ratio on the content of total flavonoids in Pueraria lobata( Willd.) Ohwi,respectively. Under the optimal extraction technology,the content of total flavonoids in Pueraria lobata( Willd.) Ohwi at different altitudes was determined.[Results] The optimum extraction process was as follows: 70%ethanol; solid-liquid ratio of 1∶ 30; 1 h reflux extraction. Under these conditions,the extraction rate of flavonoids in Pueraria lobata( Willd.) Ohwi was 11. 48%,the total flavonoids content of different kudzu parts was in the order of roots > stems > leaves,and the total flavonoids content of the sample at about an altitude of 1000 m was significantly higher than at the altitudes of 1400 m and 1700 m.[Conclusions]It was suggested that the Pueraria lobata( Willd.) Ohwi should not be cultivated as medicinal plant in too high mountains,and the stems and leaves of Pueraria lobata( Willd.) Ohwi could be used as raw materials for extracting total flavonoids. 展开更多
关键词 PUERARIA lobata(Willd.) Ohwi TOTAL FLAVONOIDS EXTRACTION technology Different ALTITUDES CONTENT determination
暂未订购
坡莫合金纳米环微磁学特性研究
2
作者 李应琛 王永鑫 +2 位作者 闫泽 刘磊 丁福康 《凝聚态物理学进展》 2020年第4期59-64,共6页
基于微磁学软件MuMax3,我们研究了外磁场下不同几何形状的磁性纳米环(Ni_(80)Fe_(20))的磁化翻转过程,除了预期的洋葱态和漩涡磁化状态外,在磁化过程中还观察到其它亚稳态。通过磁矩翻转相图和能量密度关系,分析了不同磁化状态的形成和... 基于微磁学软件MuMax3,我们研究了外磁场下不同几何形状的磁性纳米环(Ni_(80)Fe_(20))的磁化翻转过程,除了预期的洋葱态和漩涡磁化状态外,在磁化过程中还观察到其它亚稳态。通过磁矩翻转相图和能量密度关系,分析了不同磁化状态的形成和跃迁,以及磁矩翻转过程中畴壁的传播和湮灭。我们进一步研究了极化电流驱动Ni_(80)Fe_(20)/Cu/Ni_(80)Fe_(20)磁性隧道结中磁矩翻转的过程,研究发现,纳米环隧道结磁矩翻转的电流密度为3.4×10^(7) A/cm^(2),临界电流密度大小为传统隧道结的0.63倍,两者的磁矩翻转时间大致相同,约为1000 ps。 展开更多
关键词 MuMax3 坡莫合金 磁性纳米环 磁性隧道结
在线阅读 下载PDF
Implantation of human umbilical cord mesenchymal stem cells for ischemic stroke: perspectives and challenges 被引量:11
3
作者 yingchen li Guoheng Hu Qilai Chen 《Frontiers of Medicine》 SCIE CAS CSCD 2015年第1期20-29,共10页
lschemic stroke is a focal cerebral insult that often leads to many adverse neurological complications severely affecting the quality of life. The prevalence of stroke is increasing throughout the world, while the eff... lschemic stroke is a focal cerebral insult that often leads to many adverse neurological complications severely affecting the quality of life. The prevalence of stroke is increasing throughout the world, while the efficacy of current pharmacological therapies remains unclear. As a neuroregenerative therapy, the implantation of human umbilical cord mesenchymal stem cells (hUC-MSCs) has shown great possibility to restore function after stroke. This review article provides an update role of hUC-MSCs implantation in the treatment of ischemic stroke. With the unique "immunosuppressive and immunoprivilege" property, hUC-MSCs are advised to be an important candidate for aUogeneic cell treatment. Nevertheless, most of the treatments are still at primary stage and not clinically feasible at the current time. Several uncertain problems, such as culture conditions, allograft rejection, and potential tumorigenicity, are the choke points in this cellular therapy. More preclinical researches and clinical studies are needed before hUC-MSCs implantation can be used as a routinely applied clinical therapy. 展开更多
关键词 human umbilical cord mesenchymal stem cells ischemic stroke cellular therapy TRANSPLANTATION
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部